CVS Health to split pharmacy, insurance businesses into 2 separate companies
CVS Health plans to split into two publicly traded companies by mid-2028. The separation will divide its pharmacy and insurance businesses. The insurance side, to be named CVS Health, will include Aetna and other health services. The retail side, CVS Pharmacy, will comprise pharmacies and clinics. Current CEO David Joyner will lead the healthcare solutions company, while Prem Shah will head CVS Pharmacy.
How this was made

The 30-second read
Why it matters
The announcement creates two separate publicly traded entities, likely prompting re‑valuation and short‑term trading activity.
Market read
Spin‑off news is material for investors; it may drive volatility and reallocation within health‑care portfolios.
What to watch
Regulatory approvals, tax implications, and the execution timeline through 2028 could affect the ultimate benefit of the spin‑off.
Background
CVS Health is a large U.S. health‑care company operating pharmacy retail, pharmacy benefit management, and health insurance through Aetna.
Ticker impact
CVS Health announced it will split into two publicly traded companies, separating its pharmacy and insurance businesses.
potential pressure on CVS as investors reprice the combined business and seek clarity on each new entity
Spin‑offs typically trigger short‑term volatility while the market assesses the standalone prospects of the pharmacy and insurance segments.
Market effects
Healthcare sector may see re‑rating of pharmacy vs. insurance peers as the businesses are untangled.
U.S. market may see modest volatility in health‑care indices.
Limited to investors with exposure to U.S. health‑care stocks.
Counterpoint
The split could unlock value if the two businesses are undervalued together; a buy‑and‑hold of both new shares may outperform.
Key entities
- companyCVS Health
Parent company announcing the split.
- business unitAetna
Insurance arm to be part of the new CVS Health entity.



